Physician profile
Andrew E Porter
NPI 1477908184
$5,996.65
in general payments reported to CMS, 2019-2025
25 companies · $2,234 in 2025
The $2,234 reported for 2025 was more than what 94% of Physician Assistant providers received nationally (typical 2025 total: $183).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2022: $803 · 2023: $1,001 · 2024: $1,959 · 2025: $2,234.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $4,806 · Education: $387.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $4,806.25 |
| Education | $387.18 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbvie INC. | $932.53 | 2022-2025 | |
| E.R. Squibb & Sons, L.L.C. | $889.35 | 2022-2025 | Sotyktu |
| Janssen Biotech, INC. | $567.07 | 2023-2025 | Tremfya |
| Regeneron Healthcare Solutions, INC. | $462.99 | 2024-2025 | Dupixent, Libtayo |
| Ucb, INC. | $434.76 | 2024-2025 | Bimzelx |
| Genzyme Corporation | $418.34 | 2022-2025 | |
| Leo Pharma INC. | $368.59 | 2022-2025 | Adbry, Anzupgo |
| Lilly USA, LLC | $349.81 | 2022-2025 | Ebglyss, Taltz, Olumiant |
| Sun Pharmaceutical Industries INC. | $281.25 | 2023-2025 | Absorica Ld, Winlevi |
| Janssen Scientific Affairs, LLC | $237.95 | 2022 | |
| Pfizer INC. | $151.81 | 2024-2025 | |
| Galderma Laboratories, L.P. | $131.41 | 2022-2025 | Aklief, Nemluvio |
| Organon LLC | $126.18 | 2025 | Vtama, Nexplanon |
| Incyte Corporation | $114.63 | 2023-2025 | Opzelura |
| Novartis Pharmaceuticals Corporation | $111.32 | 2024-2025 |
Show all 25 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Dermavant Sciences, INC. | $80.31 | 2023-2024 | Vtama |
| Mayne Pharma Commercial LLC | $79.93 | 2022-2024 | |
| Amgen INC. | $79.51 | 2023-2025 | Otezla, Otezla |
| Verrica Pharmaceuticals INC. | $68.91 | 2023-2025 | Ycanth |
| Mallinckrodt Hospital Products INC. | $25.00 | 2025 | Acthar |
| Lnhc, INC | $19.37 | 2025 | Zelsuvmi |
| Ortho Dermatologics, A Division of Bausch Health US, LLC | $19.12 | 2022 | |
| Botanix Sb INC | $17.21 | 2025 | Sofdra |
| Epi Health, LLC | $16.08 | 2022 | |
| Stemline Therapeutics INC. | $13.22 | 2022 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Andrew Porter listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.